Our platform connects patients, clinicians and carers. It provides standard components that can be customized to develop combined medication and digital therapy products that employ precision medicine to help patients reach better outcomes.
Platform & Products
Our platform enables efficient development of personalized medicine products by integrating drugs and devices with patient-led digital experiences to support patients with long term conditions.
Creating closed loop models of care
-
Drug
Optimizing dosing and medication regimens using personalized information and feedback.
-
Digital
Providing a software platform to coach, support, and guide each patient’s journey to good health. Delivering unique insights to improve patients’ care.
-
Device
Harnessing data captured by medical devices, smartphones and wearables to support disease management and recovery.
How it works
Medication and digital therapies available through a single prescription.
Our platform connects patients, clinicians and carers. It provides standard components that can be customized to develop combined medication and digital therapy products that employ precision medicine to help patients reach better outcomes.
Our products aim to improve treatment outcomes. We want to improve patient access to precision dosing, behavioral therapy and wellness programmes. This benefits payors by reducing costs of disease management.
Medications can be combined with digital products and existing software services. This allows value to be added to existing products to improve efficacy and uptake. By collecting data on real world use, continual improvement and label expansion is made possible.
Patients receive medications and digital therapies managed on their smartphone. This places the patient at the centre of their treatment enabling effective and safe dosing. This minimizes side effects, encourages adherence and maximizes treatment efficacy.
In certain use cases, to improve treatment outcomes, patients can choose to share their data with other people involved in their support network.
Data and recommendations are shared with clinicians so they can make informed treatment decisions at an individual patient level. Collecting data between appointments means patient and clinician interactions can be optimized to improve appointment productivity.
How it works
Medication and digital therapies available through a single prescription.
Our products aim to improve treatment outcomes. We want to improve patient access to precision dosing, behavioral therapy and wellness programmes. This benefits payors by reducing costs of disease management.
Medications can be combined with digital products and existing software services. This allows value to be added to existing products to improve efficacy and uptake. By collecting data on real world use, continual improvement and label expansion is made possible.
Patients receive medications and digital therapies managed on their smartphone. This places the patient at the centre of their treatment enabling effective and safe dosing. This minimizes side effects, encourages adherence and maximizes treatment efficacy.
In certain use cases, to improve treatment outcomes, patients can choose to share their data with other people involved in their support network.
Data and recommendations are shared with clinicians so they can make informed treatment decisions at an individual patient level. Collecting data between appointments means patient and clinician interactions can be optimized to improve appointment productivity.
CLM-IN01
Insomnia
A single label combination product combining the Company’s UKCA / CE approved medical device software product for insomnia with a novel prolonged release micro-granule drug formulation.
Regulatory Submission
Key Milestones:Bioequivalence secured, UKCA and CE marking secured
Latest News:The product is currently in submission for regulatory approval.
CLM-IN01
Insomnia
CLM-HT01
Hypertension
A single label combination product linking a medical device software product designed to support patients in the management of their blood pressure through the identification of a personalized dosing regimen with integrated wellness and behavior content with a first in line anti-hypertensive.
Clinical Evaluation Completed
Key Milestones:Clinical studies completed in the UK and US demonstrating dosing optimisation
Latest News:Publication of positive clinical study results in Journal Of American Heart Association demonstrating value of dose optimisation and perzonalised care.
CLM-HT01
Hypertension
CLM-OB1
Obesity
A drug-software combination delivering more weight loss, lower side effects and greater value than the competition, both for patients with obesity and those with key co-morbidities.
Research & Development
Key Milestones:Prototype and patent estate
CLM-OB1
Obesity
CLM-P01
Chronic Pain
A single label, medication and medical device software product for patients with Chronic Pain.
Research & Development
Key Milestones:Prototype
Latest News:Early development work initiated with technology partners to identify safe ways of supporting patients with chronic pain.
CLM-P01
Chronic Pain
Talk to our team
Get in touch if you would like to speak with one of our team members.